ZTSUS
Open
Back To Top
Last Updated: Nov 20, 2019 12:34 p.m. EST Real time quote

$119.53

-0.80 -0.66%
Health Care/Life Sciences 0.80%
Previous Close
$120.33
Advanced Charting
  • $
  • %
  • Vol
Advanced Charting
23.53% vs Avg.
Volume: 495.3K 65 Day Avg. - 2.1M
Open: 120.33
Last: 119.53
119.47 Day Low/High 121.24
Day Range
78.90 52 Week Low/High 130.20

Your Watchlist

Customize MarketWatch

Have Watchlists? Log in to see them here or sign up to get started.

Symbol
Company
Price
Chg/Chg %
No Items in Watchlist

There are currently no items in this Watchlist.

No Saved Watchlists

Create a list of the investments you want to track.

Uh oh

Something went wrong while loading Watchlist.

Recently Viewed Tickers

No Recent Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

Key Data

  • Open $120.33
  • Day Range 119.47 - 121.24
  • 52 Week Range 78.90 - 130.20
  • Market Cap $57.31B
  • Shares Outstanding 478.66M
  • Public Float 475.91M
  • Beta 0.98
  • Rev. per Employee $582.5K
  • P/E Ratio 39.52
  • EPS $3.03
  • Yield 0.55%
  • Dividend $0.16
  • Ex-Dividend Date Oct 21, 2019
  • Short Interest 3.67M 10/31/19
  • % of Float Shorted 0.77%
  • Average Volume 2.11M

Performance

5 Day
  • 2.64%
1 Month
  • -1.86%
3 Month
  • -6.35%
YTD
  • 39.74%
1 Year
  • 34.79%

Recent News

  • MarketWatch
  • WSJ

Beyond Meat Is Shaking Up the Meat Industry. Animal-Health Stocks Could Take a Hit, Too.

Wall Street has high hopes for the alternative-meat industry. If the world does end up eating less animal-based protein in the future, other industries—besides just meat producers—will be affected.

Zoetis Stock Climbs Because the Pet Business Is Still Booming

Helped by a double-digit increase in its pet business, Zoetis reported third-quarter earnings that handily beat Wall Street expectations.

Zoetis shares jump 2.9% premarket after earnings top estimates

Zoetis Inc. shares rose 2.9% in premarket trade Wednesday, after the animal health company beat estimates for the third quarter. Parsippany, N.J.-based Zoetis said it had net income of $433 million. or 90 cents a share, n the quarter, up from $347 million, or 71 cents a share, in the year-earlier period. Adjusted per-share earnings came to 94 cents, ahead of the 88 cents FactSet consensus. Revenue rose 7% to $1.584 billion from $1.480 billion, also ahead of the FactSet consensus of $1.577 billion. "Our companion animal portfolio is once again the main driver of our results, growing 23% operationally based on strong sales of our parasiticide products, our key dermatology portfolio, and diagnostic revenue from the Abaxis acquisition," Chief Executive Joan Ramon Alaix said in a statement. "Livestock sales declined 4% operationally due to lower product sales in cattle, swine and fish, which were partially offset by growth in poultry." The company is now expecting full-year revenue of $6.200 billion to $6.250 billion and adjusted EPS of $3.57 to $3.62. The FactSet consensus is for revenue of $6.239 billion and EPS of $3.57. Shares have gained 42% in 2019, while the S&P 500 has gained 23%.

Zoetis stock up 2.9% premarket

Zoetis now sees full-year adj. EPS $3.57 to $3.62

Zoetis now sees full-year revenue $6.200 bln to $6.250 bln

Zoetis Q3 revenue $1.584 bln vs. $1.480 bln; FactSet consensus $1.577 bln

Zoetis Q3 adj. EPS 94 cents; FactSet consensus 88 cents

Zoetis Q3 EPS 90 cents vs. 71 cents

How to Pretend to Understand Brexit

Stocks tend to price in worst-case scenarios. A deal with the European Union—if approved by Parliament—could lead to upside for attractively priced U.K. names.

Debra Brede: Stock Opportunities Abound

The top-ranked Barron’s advisor argues for a bullish stance on stocks, ticks off several bargains, and explains how she takes inspiration from King Solomon.

Zoetis names Kristin Peck as CEO effective Jan 1, replacing Juan Ramon Alaix who is retiring

Zoetis Inc. said Thursday it has named Kristin Peck as chief executive effective Jan. 1, replacing Juan Ramon Alaix, who is retiring. Peck is currently executive vice president and group president responsible for U.S. operations, business development and strategy at the Parsippany, N.J.-based animal health company. Alaix has led the company since it was spun off from Pfizer Inc. in 2012. Shares were not yet active premarket but have gained 43% in 2019, while the S&P 500 has gained 15%.

Zoetis names Kristin Peck as CEO effective Jan 1

Zoetis’s New Drug for Dogs Will be a Big Seller, Goldman Sachs Says

Zoetis, the largest animal-health company, received an upgrade on Monday ahead of the expected regulatory approval of Simparica Trio, an oral canine drug that is expected to generate big sales.

The 3 Best Health Care Stocks So Far This Year

Health-care companies haven’t been the strongest performers in the S&P 500 this year, but two of the standouts have been pet-health firms.

Read full story

Elanco Stock Tumbles After It Announces Acquisition of Bayer’s Animal-Health Business

Big IPOs, Like Beyond Meat, Have Had a Good Year. WeWork Wants In.

Elanco Animal Health Stock Gets an Upgrade, Despite Bayer Deal Worries

Read full story

Zoetis Stock Is Up as Pet Products Lift Revenue

Walt Disney, Activision Blizzard, Kraft Heinz and Other Stocks for Investors to Watch This Week

Read full story

Investors Don’t Love Elanco’s New Tricks

on The Wall Street Journal
Read full story

Bayer to Sell Animal-Health Unit to Elanco for $7.6 Billion

on The Wall Street Journal
Read full story

After U.S. Tax Overhaul, Corporate Rates Fall but Unevenly

on The Wall Street Journal
Read full story

Companies Feel the Tariff Pinch

on The Wall Street Journal
Read full story

Animal-Health Stocks Will Continue to Shine

on The Wall Street Journal
Read full story

Eli Lilly to Offer Minority Stake in Animal-Health Business

on The Wall Street Journal
Read full story

Stocks to Watch: Macy’s, Nordstrom, Disney, Amazon, Tesla, Fox, Oracle, AMD, Micron, Monsanto, Helios

on The Wall Street Journal
Read full story

Zoetis to Buy Veterinary-Diagnostics Company Abaxis for $2 Billion

on The Wall Street Journal
Read full story

The Strong Case for Health-Care Spinoffs

on The Wall Street Journal
Read full story

Buybacks, Pension Contributions and Savings: Companies Tout Tax Benefits

on The Wall Street Journal
Read full story

Eli Lilly Exploring Spinoff of Elanco Animal-Health Business

on The Wall Street Journal
Read full story

The Reason Investors Love Spinoffs: Juicier Returns

on The Wall Street Journal
Read full story

When Activists Enter the Kitchen, the CFOs Feel the Heat

on The Wall Street Journal

High-Tech Tagging Comes to the Ranch

on The Wall Street Journal
Read full story

Cowboys Turn to High-Tech Ear Tags to Monitor Animal Health

on The Wall Street Journal

The Morning Risk Report: Uneven Enforcement Worries U.S. Firms in China

on The Wall Street Journal
Read full story

Valeant Pays up for New CFO Herendeen

on The Wall Street Journal
Read full story

Valeant Names Zoetis Executive as CFO

on The Wall Street Journal
Read full story

A Window of Opportunity Cracks Open at Valeant

on The Wall Street Journal
Read full story

Stocks to Watch: Medivation, Pfizer, Valeant

on The Wall Street Journal

Recent News

  • Other News
  • Press Releases

Zacks.com featured highlights include: Heico, Microsoft, Zoetis and Cadence Design System

Zacks.com featured highlights include: Heico, Microsoft, Zoetis and Cadence Design System

on Zacks.com

4 GARP Stocks for a Winning Portfolio

Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

on Zacks.com

Boring No More: Agriculture and Food Investing Gets A Sexy New ETF

Boring No More: Agriculture and Food Investing Gets A Sexy New ETF

on Benzinga.com

3 Big Stock Charts for Wednesday: Stryker, Zoetis, and Coty

3 Big Stock Charts for Wednesday: Stryker, Zoetis, and Coty

on InvestorPlace.com

Free Cash Flow Is King: The TrimTabs ETF Approach (Podcast Transcript)

Free Cash Flow Is King: The TrimTabs ETF Approach (Podcast Transcript)

on Seeking Alpha

Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?

Style Box ETF report for FTCS

on Zacks.com

Zoetis: Near-Term Headwinds, But Long-Term 10% Annual Growth

Zoetis: Near-Term Headwinds, But Long-Term 10% Annual Growth

on Seeking Alpha

JAZZ or ZTS: Which Is the Better Value Stock Right Now?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

on Zacks.com

Zoetis Inc. (ZTS) CEO Juan Ramon Alaix on Q3 2019 Results - Earnings Call Transcript

Zoetis Inc. (ZTS) CEO Juan Ramon Alaix on Q3 2019 Results - Earnings Call Transcript

on Seeking Alpha

Polen Capital Global Growth Strategy Portfolio Manager Commentary Q3 2019

Polen Capital Global Growth Strategy Portfolio Manager Commentary Q3 2019

on Seeking Alpha

10-Q: ZOETIS INC.

10-Q: ZOETIS INC.

on Edgar Online - (EDG = 10Q, 10K)

Zoetis (ZTS) Beats on Earnings in Q3, Reports In-Line Sales

Zoetis (ZTS) beats earnings estimates, while sales are in line in the third quarter of 2019.

on Zacks.com

Polen Capital Focus Growth Strategy Portfolio Manager Commentary Q3 2019

Polen Capital Focus Growth Strategy Portfolio Manager Commentary Q3 2019

on Seeking Alpha

Zoetis (ZTS) Tops Q3 Earnings and Revenue Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 5.62% and 0.17%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

on Zacks.com

Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q3 2019 Update

Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q3 2019 Update

on Seeking Alpha

Zoetis Q3 earnings up 25%; guidance raised; shares up 3% premarket

Zoetis Q3 earnings up 25%; guidance raised; shares up 3% premarket

on Seeking Alpha

Notable earnings before Thursday’s open

Notable earnings before Thursday’s open

on Seeking Alpha

Zoetis Q3 2019 Earnings Preview

Zoetis Q3 2019 Earnings Preview

on Seeking Alpha

Free Cash Flow Is King: The TrimTabs ETF Approach (Podcast)

Free Cash Flow Is King: The TrimTabs ETF Approach (Podcast)

on Seeking Alpha

Zoetis (ZTS) to Report Q3 Earnings: What's in the Cards?

Zoetis (ZTS) is expected to provide pipeline updates during the third-quarter earnings call.

on Zacks.com

Clinical Trial Imaging Market Application, Revenue, Technology, Analysis By BioTelemetry, Inc, IXICO plc, Resonance Health, Bioclinica, ICON plc

Clinical Trial Imaging Market Application, Revenue, Technology, Analysis By BioTelemetry, Inc, IXICO plc, Resonance Health, Bioclinica, ICON plc

on Reporthive Research

Microbial Identification Panel Market By || Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA

Microbial Identification Panel Market By || Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA

on Reporthive Research

Hereditary Cancer Testing Market (2019-2024), Analysis by Top Vendors Hologic Inc., Koninklijke Philips N.V., Quest Diagnostics Incorporated, Myriad Genetics, Inc.

Hereditary Cancer Testing Market (2019-2024), Analysis by Top Vendors Hologic Inc., Koninklijke Philips N.V., Quest Diagnostics Incorporated, Myriad Genetics, Inc.

on Reporthive Research

Animal Genetics Market Size, Growth, Opportunity and Forecast to 2025

Animal Genetics Market Size, Growth, Opportunity and Forecast to 2025

on AmericaNewsHour

Global Fish Vaccine Market Grow at a CAGR of 6.5% by 2027|Zoetis (ZTS), Merck & Co. (MRK), HIPRA, Seppic, Nisseiken Co.

Global Fish Vaccine Market Grow at a CAGR of 6.5% by 2027|Zoetis (ZTS), Merck & Co. (MRK), HIPRA, Seppic, Nisseiken Co.

on AmericaNewsHour

Point of Care Testing Market to Grow as New Home-Based Devices Gain Popularity Prominent Players: ARKRAY, Inc, Abaxis, Inc, Abbott, Alfa Scientific Designs, Inc, Ascencia Diabetes Care Holdings AG, Beckman Coulter

Point of Care Testing Market to Grow as New Home-Based Devices Gain Popularity Prominent Players: ARKRAY, Inc, Abaxis, Inc, Abbott, Alfa Scientific Designs, Inc, Ascencia Diabetes Care Holdings AG, Beckman Coulter

on The Express Wire

Poultry Diagnostics Market Size, Growth, Opportunity and Forecast to 2025

Poultry Diagnostics Market Size, Growth, Opportunity and Forecast to 2025

on AmericaNewsHour

Veterinary Medicine Market Is Anticipated To Reach $39.1 Billion By 2026: Grand View Research, Inc.

Veterinary Medicine Market Is Anticipated To Reach $39.1 Billion By 2026: Grand View Research, Inc.

on ABNewswire

Mexican Veterinary Healthcare Market Research and Clinical Survey 2019 to 2024 | Zoetis Animal Healthcare, Merck Animal Health, Bayer Animal Health

Mexican Veterinary Healthcare Market Research and Clinical Survey 2019 to 2024 | Zoetis Animal Healthcare, Merck Animal Health, Bayer Animal Health

on Market Insight Reports

Animal Pharmaceutical Industry: Time to Invest in emerging Markets | Leading Players: Zoetis, Bayer, Boehringer Ingelheim, Vetoquinol

Animal Pharmaceutical Industry: Time to Invest in emerging Markets | Leading Players: Zoetis, Bayer, Boehringer Ingelheim, Vetoquinol

on HTF Market Intelligence

Tissue Engineering Market Share, Size, industry Trends, Outlook, Revenue, Manufacturers, Demand and Forecast to 2024 Acelity, Integra Lifesciences, C. R. Bard, Zimmer Biomet

Tissue Engineering Market Share, Size, industry Trends, Outlook, Revenue, Manufacturers, Demand and Forecast to 2024 Acelity, Integra Lifesciences, C. R. Bard, Zimmer Biomet

on Reporthive Research

Skin Substitutes Market Share, Size Swot Analysis By Major Trends From 2019-2024 | Medtronic (Covidien), BSN Medical, Integra LifeSciences Corporation, Smith & Nephe

Skin Substitutes Market Share, Size Swot Analysis By Major Trends From 2019-2024 | Medtronic (Covidien), BSN Medical, Integra LifeSciences Corporation, Smith & Nephe

on Reporthive Research

Neurodegenerative Disease Market forecast to 2024 | Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB

Neurodegenerative Disease Market forecast to 2024 | Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB

on Reporthive Research

Farm Animal Healthcare Market 2019 Business Growth, Market Size and Comprehensive Research Study Forecast to 2025

Farm Animal Healthcare Market 2019 Business Growth, Market Size and Comprehensive Research Study Forecast to 2025

on marketresearch.biz

Veterinary Artificial Insemination Market Will Make Huge Impact By Generating About USD 2.5 Billion By 2026 With Major Players: Genus Plc, Select Sire, Semex, Swine Genetics, Zoetis.

Veterinary Artificial Insemination Market Will Make Huge Impact By Generating About USD 2.5 Billion By 2026 With Major Players: Genus Plc, Select Sire, Semex, Swine Genetics, Zoetis.

on ABNewswire

Veterinary Molecular Diagnostics Market: Opportunities and Forecast Assessment, 2019-2024

Veterinary Molecular Diagnostics Market: Opportunities and Forecast Assessment, 2019-2024

on Heraldkeepers

Veterinary Pharmaceuticals Market Volume Analysis, Value Share and Key Trends 2019 to 2025

Veterinary Pharmaceuticals Market Volume Analysis, Value Share and Key Trends 2019 to 2025

on marketresearch.biz

Point Of Care Diagnostics (POCD) Market Growing at High CAGR by 2024 - Roche Diagnostics, Abbott Diagnostics Inc., Abaxis Inc., Spectral Diagnostics, Siemens Healthcare

Point Of Care Diagnostics (POCD) Market Growing at High CAGR by 2024 - Roche Diagnostics, Abbott Diagnostics Inc., Abaxis Inc., Spectral Diagnostics, Siemens Healthcare

on Profound

Porcine Vaccine Market Clinical Analysis 2019 to 2025

Porcine Vaccine Market Clinical Analysis 2019 to 2025

on Market Insight Reports

China Veterinary Healthcare Market Size, Trends, Share and Forecast Report By 2022

China Veterinary Healthcare Market Size, Trends, Share and Forecast Report By 2022

on AmericaNewsHour

Zoetis Inc.

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ. (See Full Profile)

Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 15 Full Ratings

Competitors

Name Chg % Market Cap
Eli Lilly & Co. -0.47% $110.51B
Immucell Corp. 2.81% $35.55M
Sanofi ADR -0.93% $115.82B
Pfizer Inc. -1.16% $208.42B
Phibro Animal Health Corp. 0.52% $940.56M
Competitor Data Provided ByCapital Cube Logo